| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-01-13 15:31 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Oliver, Robert Lee
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$68,290
+1,365,800 vol $0.05 each |
1,365,800 | |
| Filed 2023-01-13 15:31 Tx date 2021-04-20 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Oliver, Robert Lee
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-13 15:30 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Oliver, Robert Lee
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
16 - Acquisition or disposition under a prospectus exemption
|
$68,290
+1,365,800 vol $0.05 each |
1,365,800 | |
| Filed 2023-01-13 15:30 Tx date 2021-04-20 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Oliver, Robert Lee
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-13 15:28 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Spigarelli, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$106,703
+2,134,062 vol $0.05 each |
2,134,062 | |
| Filed 2023-01-13 15:27 Tx date 2021-04-04 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Spigarelli, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-13 15:23 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Spigarelli, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares
16 - Acquisition or disposition under a prospectus exemption
|
$106,703
+2,134,062 vol $0.05 each |
2,134,062 | |
| Filed 2023-01-13 15:22 Tx date 2021-04-04 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Spigarelli, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-12 16:31 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Levine, Evan Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$254,902
+5,098,042 vol $0.05 each |
5,098,042 | |
| Filed 2023-01-12 16:30 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Levine, Evan Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-12 16:28 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Levine, Evan Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Subordinate Voting Shares
16 - Acquisition or disposition under a prospectus exemption
|
$254,902
+5,098,042 vol $0.05 each |
5,098,042 | |
| Filed 2023-01-12 16:27 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Levine, Evan Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-12 16:22 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Davis, Noah Isidore
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$254,902
+5,098,042 vol $0.05 each |
5,098,042 | |
| Filed 2023-01-12 16:20 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Davis, Noah Isidore
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-12 16:19 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Davis, Noah Isidore
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Subordinate Voting Shares
16 - Acquisition or disposition under a prospectus exemption
|
$254,902
+5,098,042 vol $0.05 each |
5,098,042 | |
| Filed 2023-01-12 14:30 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Davis, Noah Isidore
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-12 14:19 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Carmel, Ross David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$66,395
+1,327,900 vol $0.05 each |
1,327,900 | |
| Filed 2023-01-12 14:13 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Carmel, Ross David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-12 14:10 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Carmel, Ross David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares
16 - Acquisition or disposition under a prospectus exemption
|
$66,395
+1,327,900 vol $0.05 each |
1,327,900 | |
| Filed 2023-01-12 14:09 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Carmel, Ross David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|